Life Sciences

The life sciences industry is formulating the future — and reinventing itself in the process.

Investor interest, technological advancements and collaborations are driving innovation. But the path to innovation is not without challenges. As they pursue drug development, growth-stage biotechs, med device companies and large pharmaceuticals alike will face financial risk, changing regulations, supply chain disruption and uncertain ROI.  

To seize new opportunities for growth while maintaining stability, life sciences companies need to capitalize on data, optimize performance, manage risk, fund growth and claim R&D tax credits to drive innovation. 

BDO’s Life Sciences consulting practice offers a full suite of tax, assurance and advisory services to help clients thrive in this evolving space. Our deep industry experience makes us a valuable catalyst for our clients’ success. Our BioProcess Technology Group (BPTG) provides pharmaceutical consulting and technical support with Chemistry, Manufacturing and Controls (CMC) across each stage of the drug development process, from pre-clinical research through commercialization. We also assist with ESG, including helping facilities become LEED certified and documenting clinical trial transparency.  

In life sciences, scientific and technological advancement creates opportunity: bringing investor interest, growth potential and competitive advantage. BDO stands ready to assist with technical development, risk management, revenue optimization and accelerating speed to market.